Searchable abstracts of presentations at key conferences in endocrinology

ea0059p091 | Diabetes & cardiovascular | SFEBES2018

Glycaemic control in group 2 license holders with diabetes mellitus

Drummond Samantha , Chalmers John , Gupta Saket

Background: Diabetes is a metabolic disorder characterized by chronic hyperglycaemia as a result of defective insulin secretion, insulin action or a combination. Poor glycaemic control increases the risk of microvascular and macrovascular complications. For group two driving license holders with diabetes there are specific requirements set out by the Driver and Vehicle Licensing Agency. It is therefore hypothesised that this patient group is likely to aim for less tight glycae...

ea0070aep62 | Adrenal and Cardiovascular Endocrinology | ECE2020

Reducing short synacthen tests by deriving a novel baseline and 30 min cortisol level for a scottish population

McAleer Pauline , Johnston Joy , Gupta Saket

Introduction: The Short Synachten Test (SST) is the gold standard test for assessing adrenal insufficiency, however these can be time and resource consuming. Improved cortisol assays (Scottish consensus) currently advise a cut-off of 430 nmol/l at 30 minutes . However, there is no clarity about the optimum baseline cortisol level and recommendations range varies from 300–500 nmol/l.The aim of this study was to establish a single baseline cortisol c...

ea0050ep111 | Thyroid | SFEBES2017

Nivolumab induced thyroid dysfunction in a 61 year old male with non-small cell lung cancer (NSCLC)

Nasralla Patrick , Connolly Carol , Little Felicity , Gupta Saket

Background: Nivolumab is a programmed death receptor-1 blocking antibody and the first to gain regulatory approval for use in non-small cell lung cancer (NSCLC). Whilst well tolerated in clinical trials, 3% of patients in a phase Ib study displayed thyroid dysfunction. Diagnosis and referral to appropriate specialties is a challenge in complex cancer cases where symptoms are often multi-factorial. Improved knowledge of the potential complications of new and novel...

ea0050ep111 | Thyroid | SFEBES2017

Nivolumab induced thyroid dysfunction in a 61 year old male with non-small cell lung cancer (NSCLC)

Nasralla Patrick , Connolly Carol , Little Felicity , Gupta Saket

Background: Nivolumab is a programmed death receptor-1 blocking antibody and the first to gain regulatory approval for use in non-small cell lung cancer (NSCLC). Whilst well tolerated in clinical trials, 3% of patients in a phase Ib study displayed thyroid dysfunction. Diagnosis and referral to appropriate specialties is a challenge in complex cancer cases where symptoms are often multi-factorial. Improved knowledge of the potential complications of new and novel...

ea0025p100 | Clinical biochemistry | SFEBES2011

The beneficial effects of long-acting octreotide in a patient with concomitant metastatic neuroendocrine tumour and anaemia due to lower digestive bleeding

Gupta Saket , McGowan Lisa , O'Shea Donal , Tamagno Gianluca

Somatostatin analogues (SA) represent the most effective medical treatment for the control of neuroendocrine tumour (NET) symptoms, like carcinoid syndrome. Recently there has been evidence of lengthened time to tumour progression in patients with midgut carcinoid treated with octreotide. Nevertheless, a number of new therapeutic indications and the clinical effectiveness of SA for other clinical conditions are appearing. A 69-year-old man was investigated for anaemia (haemogl...

ea0020p44 | Adrenal | ECE2009

A rare cause of hyponatraemia presenting as acute adrenal insufficiency: bilateral adrenal haemorrhage

Gupta Saket , Hyde Sarah , Abbasi Babar , Thomas Sam , Hoashi Shu

We report a rare case of 37 years female of Greek and Irish extraction with a history of thalassemia trait, who presented with generalised weakness and severe loin and pelvic pain 9 days post vaginal hysterectomy and 3 days after hospital discharge. After readmission, she developed mild pyrexia (37.5°C), hypotension, mild hyponatraemia with plasma sodium which fell from 138 to 131 mM and early signs of acute respiratory distress syndrome. A Short Synacthen test was perfor...

ea0077lb17 | Late Breaking | SFEBES2021

Challenges in the diagnosis and management of type 1 diabetes in older adults

Symington Andrew DF , Burns Denise , Robsertson Sharon , Roslan Johan , Gupta Saket

Aim: Diagnosis of type 1 diabetes in older adults can be challenging, and management can be complicated by co-morbid conditions. In this study we aimed to compare glycaemic control, microvascular complications and diabetic emergencies (severe hypoglycaemia and diabetic ketoacidosis) in the early years following diagnosis between younger adults (<50) and older adults (≥50).Method: A retrospective cohort study was performed on people with newly d...

ea0038p313 | Pituitary | SFEBES2015

A prospective observational study of the causation and management of SIADH in a tertiary referral hospital

Yunus Saba , Questa Martin , Slattery David , Gupta Saket , Tormey William , Thompson C J

Background: SIADH is the most frequent underlying cause of hyponatraemia but is frequently ignored and suboptimally treated.Aim: To identify the treatment applied in clinical practice for hyponatraemia due to SIADH and to evaluate the effect of fluid deprivation.Method: A prospective, non-intervention observational study of a sequentially evaluated cohort of hyponatraemic patients during first 48 h after hospitalization from Januar...

ea0037gp.17.07 | Pituitary–Neuroendocrinology and central salt regulation | ECE2015

Heterogenous patterns of recovery from adipsic diabetes insipidus in adult patients

Hernandez Martin Cuesta , Dineen Rosemary , Gupta Saket , Salehmohamed Ridhwaan , Thompson Christopher

Introduction: The natural history of adipsic diabetes insipidus (ADI) is not completely understood. Isolated case reports suggest occasional recovery of adipsia. We present the follow up of a cohort of 12 patients with ADI.Setting: National pituitary unit with interest in diabetes insipidus.Methods: ADI was identified by demonstrating absent thirst and AVP responses to hypertonic saline infusion. Results 12 patients with ADI were i...

ea0037ep703 | Pituitary: basic and neuroendocrinology | ECE2015

Mortality in SIADH is similar to that in non-SIADH hyponatraemia; preliminary data

Thompson Christopher J , Slattery David , Gupta Saket , Tormey William , Hernandez Martin Cuesta

Introduction: Excess mortality due to hyponatraemia is well documented but it is not clear whether the mortality associated with SIADH is different to that associated with non-SIADH hyponatraemia (NSH).Methods/design: Prospective evaluation of all patients admitted with or developing hyponatraemia in a tertiary hospital (pNa <130 mmol/l) in January 2015. Diagnosis of SIADH was based on standard clinical and biochemical criteria (pNa, spot urine sodiu...